Home Newsletters Mesenchymal Cell News ac4C Acetylation of RUNX2 Catalyzed by NAT10 Promotes Osteogenic Differentiation of Bone...

ac4C Acetylation of RUNX2 Catalyzed by NAT10 Promotes Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and Prevents Ovariectomy-Induced Bone Loss

0
Investigators explored the relationships among osteoblast differentiation, N-acetyltransferase 10 (NAT10) , and N4-acetylcytidine (ac4C) and found that NAT0 expression and the ac4C level of total RNA were decreased in the bone tissues of OVX mice and osteoporosis patients.
[Molecular Therapy-Nucleic Acids]

Sorry, but the selected Zotpress account can't be found.

AbstractFull ArticleGraphical Abstract
Exit mobile version